Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
56.59
-1.02 (-1.77%)
Mar 9, 2026, 1:22 PM EDT - Market open
Monopar Therapeutics Market Cap
Monopar Therapeutics has a market cap or net worth of $378.17 million as of March 9, 2026. Its market cap has increased by 51.36% in one year.
Market Cap
378.17M
Enterprise Value
232.02M
1-Year Change
51.36%
Ranking
Category
Stock Price
$56.59
Market Cap Chart
Since December 19, 2019, Monopar Therapeutics's market cap has increased from $276.16M to $378.17M, an increase of 36.94%. That is a compound annual growth rate of 5.19%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NovaBridge Biosciences | 403.52M |
| Autolus Therapeutics | 401.88M |
| Crescent Biopharma | 400.89M |
| PureTech Health | 400.20M |
| Enanta Pharmaceuticals | 392.92M |
| PepGen | 390.83M |
| Benitec Biopharma | 388.45M |
| Armata Pharmaceuticals | 385.91M |